These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8449017)
1. Evaluation of the clinical performance of a levonorgestrel-releasing IUD, up to seven years of use, in Campinas, Brazil. Díaz J; Faúndes A; Díaz M; Marchi N Contraception; 1993 Feb; 47(2):169-75. PubMed ID: 8449017 [TBL] [Abstract][Full Text] [Related]
2. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs. Chi IC Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615 [TBL] [Abstract][Full Text] [Related]
3. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties. Luukkainen T; Toivonen J Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882 [TBL] [Abstract][Full Text] [Related]
4. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices. Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785 [TBL] [Abstract][Full Text] [Related]
5. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study. Nilsson CG; Allonen H; Diaz J; Luukkainen T Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636 [TBL] [Abstract][Full Text] [Related]
6. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices. Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771 [TBL] [Abstract][Full Text] [Related]
7. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study. Sivin I; el Mahgoub S; McCarthy T; Mishell DR; Shoupe D; Alvarez F; Brache V; Jimenez E; Diaz J; Faundes A Contraception; 1990 Oct; 42(4):361-78. PubMed ID: 2124179 [TBL] [Abstract][Full Text] [Related]
8. Five years' experience with levonorgestrel-releasing IUDs. Luukkainen T; Allonen H; Haukkamaa M; Lähteenmäki P; Nilsson CG; Toivonen J Contraception; 1986 Feb; 33(2):139-48. PubMed ID: 3084167 [TBL] [Abstract][Full Text] [Related]
9. Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS. Sivin I; Stern J; Coutinho E; Mattos CE; el Mahgoub S; Diaz S; Pavez M; Alvarez F; Brache V; Thevenin F Contraception; 1991 Nov; 44(5):473-80. PubMed ID: 1797462 [TBL] [Abstract][Full Text] [Related]
10. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study. Wildemeersch D; Schacht E Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454 [TBL] [Abstract][Full Text] [Related]
11. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Andersson K; Odlind V; Rybo G Contraception; 1994 Jan; 49(1):56-72. PubMed ID: 8137626 [TBL] [Abstract][Full Text] [Related]
12. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic. Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802 [TBL] [Abstract][Full Text] [Related]
13. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study. Luukkainen T; Allonen H; Haukkamaa M; Holma P; Pyörälä T; Terho J; Toivonen J; Batar I; Lampe L; Andersson K Contraception; 1987 Aug; 36(2):169-79. PubMed ID: 3123132 [TBL] [Abstract][Full Text] [Related]
14. Acceptability of an experimental intracervical device: results of a study controlling for selection bias. Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982 [TBL] [Abstract][Full Text] [Related]
15. Sustained intrauterine release of levonorgestrel over five years. Nilsson CG; Lahteenmaki PL; Luukkainen T; Robertson DN Fertil Steril; 1986 Jun; 45(6):805-7. PubMed ID: 3086130 [TBL] [Abstract][Full Text] [Related]
16. Acceptability and performance of the levonorgestrel-releasing intrauterine system (Mirena) in Campinas, Brazil. Diaz J; Bahamondes L; Monteiro I; Petta C; Hildalgo MM; Arce XE Contraception; 2000 Aug; 62(2):59-61. PubMed ID: 11102588 [TBL] [Abstract][Full Text] [Related]
17. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices. Heinemann K; Reed S; Moehner S; Minh TD Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350 [TBL] [Abstract][Full Text] [Related]
18. A morphometric study on the endometrial activity of women before and after one year with LNG-IUD in situ. Gu Z; Zhu P; Luo H; Zhu X; Zhang G; Wu S Contraception; 1995 Jul; 52(1):57-61. PubMed ID: 8521716 [TBL] [Abstract][Full Text] [Related]
19. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use. Xiao B; Zeng T; Wu S; Sun H; Xiao N Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977 [TBL] [Abstract][Full Text] [Related]